Lupin aims to enter Chinese market in the next one year

Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time. Mumbai-headquartered Lupin is firming up plans to......

Lupin sells Japan arm to Unison for Rs 3,702 cr

The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India. Pharma major Lupin has divested its entire stake in its Japanese subsidiary,......

Sun Pharma's Dilip Shanghvi takes 99% pay cut

As on July 31, the valuation of his shareholding in the company stood at Rs 9,830 crore. The founder and managing director (MD) of the country’s largest pharmaceutical firm Sun......

Why Indian pharma cos are gung-ho about the US mkt

While companies continue to face regulatory pressure leading to higher costs, they see an uptick from the launch of differentiated and high-margin products. Illustration: Uttam Ghosh/Rediff.com......